V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20218111 | 20181399 | 1.53 | 92.2 | Palliative (P) | 2017-05-07 | 2017-05-14 | Oxaliplatin + Modified de Gramont | null | N | OXALIPLATIN + MDG | 100856685 |
| 20218493 | 20181400 | 1.5 | 58 | Curative (C) | 2019-03-14 | 2019-03-26 | CARBOPLATIN + PACLITAXEL + RT | N | Y | CARBOPLATIN + PACLITAXEL | 100056429 |
| 20219015 | 20181401 | 1.8 | 72.8 | Palliative (P) | 2018-10-26 | 2018-11-09 | Capecitabine (21 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 100687325 |
| 20219732 | 20181402 | 1.89 | 80.95 | null | 2019-07-11 | 2019-07-22 | CISPLATIN + GEMCITABINE | 02 | null | CISPLATIN + GEMCITABINE | 101424888 |
| 20220179 | 20181404 | 1.51 | 51.05 | 03 | 2019-12-16 | 2019-12-21 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | CISPLATIN + GEMCITABINE | 101150997 |
| 20220243 | 20181405 | 1.49 | 79.2 | Curative (C) | 2017-07-02 | 2017-07-19 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100340220 |
| 20220352 | 20181406 | 1.76 | 63.75 | null | 2018-02-12 | 2018-10-28 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101225375 |
| 20220800 | 20181407 | 1.69 | 65.3 | Palliative (P) | 2020-07-03 | 2020-07-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100941969 |
| 20221103 | 20181408 | 1.51 | 73 | Palliative (P) | 2017-04-13 | 2017-04-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101482232 |
| 20221118 | 20181409 | 1.87 | 67 | Palliative (P) | 2017-07-09 | 2017-07-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100595490 |
| 20221911 | 20181410 | 1.76 | 43.3 | Palliative (P) | 2017-11-16 | 2017-11-20 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100526766 |
| 20222025 | 20181411 | 1.61 | 65.6 | Palliative (P) | 2020-07-18 | 2020-10-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100851418 |
| 20223899 | 20181412 | 1.75 | 108.4 | null | 2019-06-10 | 2019-08-06 | Trastuzumab 21 day maintenance | 2 | null | TRASTUZUMAB | 101350599 |
| 20224037 | 20181413 | 1.83 | 72.7 | null | 2018-07-27 | 2018-08-11 | TRASTUZUMAB | 02 | null | TRASTUZUMAB | 101596662 |
| 20224653 | 20181414 | 1.81 | 75.3 | Palliative (P) | 2019-09-13 | 2019-09-15 | Cetuximab 14 day | 02 | N | TRASTUZUMAB | 100633752 |
| 20224935 | 20181415 | 1.79 | 77.2 | Palliative (P) | 2016-10-02 | 2016-10-04 | Irinotecan + Modified De Gramont | 02 | null | IRINOTECAN + MDG | 100659852 |
| 20010911 | 20181416 | 1.7 | 62 | Adjuvant (A) | 2020-04-12 | 2020-04-27 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 99 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101340964 |
| 20022145 | 20181418 | 1.68 | 112 | Adjuvant (A) | 2021-05-07 | 2021-05-21 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101355962 |
| 20028872 | 20181419 | 1.72 | 92 | null | 2022-01-17 | 2022-01-31 | Panitumumab | null | null | PANITUMUMAB | 100200258 |
| 20031197 | 20181420 | 1.82 | 59.4 | null | 2019-07-11 | 2019-07-25 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 101805692 |
| 20032626 | 20181422 | 1.71 | 63.15 | null | 2020-03-31 | 2020-05-11 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 101198710 |
| 20036226 | 20181423 | 1.59 | 60.5 | Palliative (P) | 2018-04-03 | 2018-04-04 | Cisplatin + Fluorouracil + RT 5day | 02 | N | CISPLATIN + FLUOROURACIL | 101801977 |
| 20038481 | 20181424 | 1.79 | 77.3 | Adjuvant (A) | null | 2019-05-18 | null | 2 | N | ECX | 100229133 |
| 20047432 | 20181425 | 1.79 | 86.4 | Palliative (P) | 2021-05-01 | 2021-05-08 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 101205070 |
| 20047460 | 20181426 | 1.71 | null | null | 2019-02-13 | 2019-08-07 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101234913 |
| 20048023 | 20181427 | 1.67 | 58.1 | Palliative (P) | 2019-04-20 | 2019-04-21 | IRINOTECAN + MDG + PANITUMUMAB | Y | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100262178 |
| 20052570 | 20181428 | 1.75 | 76.5 | Palliative (P) | 2018-01-21 | 2018-01-28 | Trial Unspecified | 02 | null | TRIAL | 101319743 |
| 20053056 | 20181429 | 1.66 | 57 | Curative (C) | null | 2020-05-02 | Panitumumab + Irinotecan + MdG | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101457667 |
| 20078310 | 20181431 | 0 | null | null | 2017-02-24 | 2017-05-11 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100647413 |
| 20078985 | 20181432 | 0 | 105 | Palliative (P) | 2020-01-28 | 2020-02-28 | null | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100782911 |
| 20111191 | 20181433 | 0 | 48.5 | Palliative (P) | 2021-01-15 | 2021-06-16 | LENVATINIB | 02 | N | LENVATINIB | 100997276 |
| 20112751 | 20181434 | 0 | null | Palliative (P) | 2022-05-20 | 2022-05-24 | LANREOTIDE | 02 | N | LANREOTIDE | 101260811 |
| 20124005 | 20181435 | 0 | null | null | 2021-02-20 | 2021-02-21 | null | 02 | null | LENVATINIB | 101570061 |
| 20128425 | 20181436 | 0 | null | null | 2021-02-08 | 2021-03-25 | OXALIPLATIN + MDG + PANITUMUMAB | 2 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101186030 |
| 20148558 | 20181437 | 1.52 | 77.4 | null | 2022-01-25 | 2022-02-04 | CARBOPLATIN | N | null | CARBOPLATIN | 101213518 |
| 20155475 | 20181438 | 1.95 | 68.6 | null | 2021-09-18 | 2021-09-21 | Ralitrexed | 02 | null | RALTITREXED | 101204404 |
| 20169180 | 20181439 | null | null | Palliative (P) | 2015-08-13 | 2018-03-18 | null | null | N | REGORAFENIB | 100813839 |
| 20184820 | 20181440 | 1.64 | 69.2 | null | null | 2016-08-26 | null | null | null | CAPECITABINE + TEMOZOLOMIDE | 100129984 |
| 20197298 | 20181441 | 1.55 | 53.95 | null | 2022-05-07 | 2022-05-07 | IMATINIB | N | null | IMATINIB | 101227674 |
| 20201314 | 20181442 | 1.68 | 68 | null | null | 2018-10-23 | null | null | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101256435 |
| 20206048 | 20181445 | 1.76 | 66.8 | null | 2020-02-05 | 2020-03-02 | null | 02 | null | EVEROLIMUS | 101257517 |
| 20206119 | 20181446 | 1.73 | null | Palliative (P) | 2018-04-07 | 2018-04-07 | EVEROLIMUS | 02 | N | EVEROLIMUS | 100637538 |
| 20208450 | 20181447 | 1.72 | 60.4 | null | 2021-01-28 | 2021-02-01 | null | 02 | null | EVEROLIMUS | 101828578 |
| 20211578 | 20181449 | 1.78 | 88 | null | 2021-10-14 | 2022-05-16 | Capecitabine + Streptozocin | 02 | null | ANAGRELIDE | 100774675 |
| 20214585 | 20181450 | 1.69 | 95.9 | Palliative (P) | 2018-07-31 | 2018-08-20 | Bortezomib + Daratumumab | 02 | N | SCOPE2 TRIAL | 100678103 |
| 20218161 | 20181451 | 1.85 | 53.4 | Neo-adjuvant (N) | 2018-02-04 | 2019-10-26 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 100382991 |
| 20039998 | 20181452 | 1.8 | 67 | Palliative (P) | 2021-09-02 | 2021-09-09 | IBRUTINIB | 02 | N | COSMIC TRIAL | 101839329 |
| 20049933 | 20181453 | 1.82 | 69.75 | 03 | 2021-02-05 | 2022-05-30 | IPILIMUMAB + NIVOLUMAB | 02 | N | TRASTUZUMAB + VINORELBINE | 100460285 |
| 20112612 | 20181454 | 1.46 | 80 | Palliative (P) | 2020-03-05 | 2020-04-09 | null | 02 | null | CAPECITABINE + CETUXIMAB + OXALIPATIN | 101479073 |
| 20225316 | 20181455 | 1.71 | 55 | Palliative (P) | 2019-04-28 | 2019-04-28 | CISPLATIN + EPIRUBICIN | null | N | DOXORUBICIN + STREPTOZOCIN | 101453265 |